𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A peptidomimetic inhibitor of matrix metalloproteinases containing a tetherable linker group

✍ Scribed by Yang Cao; Tristan I. Croll; Simone C. Rizzi; Gary K. Shooter; Helen Edwards; Kathleen Finlayson; Zee Upton; Tim R. Dargaville


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
289 KB
Volume
96A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Successful wound repair and normal turnover of the extracellular matrix relies on a balance between matrix metalloproteinases (MMPs) and their natural tissue inhibitor of metalloproteinases (TIMPs). When overexpression of MMPs and abnormally high levels of activation or low expression of TIMPs are encountered, excessive degradation of connective tissue and the formation of chronic ulcers can occur. One strategy to rebalance MMPs and TIMPs is to use inhibitors. We have designed a synthetic pseudopeptide inhibitor with an amine linker group based on a known high‐affinity peptidomimetic MMP inhibitor and have demonstrated inhibition of MMP‐1, ‐2, ‐3, and ‐9 activity in standard solutions. The inhibitor was also tethered to a polyethylene glycol hydrogel using a facile reaction between the linker unit on the inhibitor and the hydrogel precursors. After tethering, we observed inhibition of the MMPs although there was an increase in the IC~50~s that was attributed to poor diffusion of the MMPs into the hydrogels, reduced activity of the tethered inhibitor, or incomplete incorporation of the inhibitor into the hydrogels. When the tethered inhibitors were tested against chronic wound fluid, we observed partial inhibition in proteolytic activity suggesting this approach may prove useful in rebalancing MMPs within chronic wounds. Β© 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 2011.


πŸ“œ SIMILAR VOLUMES


Matrix metalloproteinases: a multifuncti
✍ Graeme I. Murray πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 59 KB πŸ‘ 2 views

The matrix metalloproteinases are a large group of zinc-containing proteases with a central role in the degradation of all types of extracellular matrix. Increased matrix degradation is a characteristic feature of several disease processes, most notably tumour invasion; it is now widely recognized t

Low molecular weight inhibitors of matri
✍ Erika H. M. Kerkvliet; Ineke D. C. Jansen; Ton A. M. Schoenmaker; Andy J. P. Doc πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Background: In the current study, the authors investigated the effects of synthetic low molecular weight inhibitors of matrix metalloproteinases (mmps) on the expression and activation of mmp-2 in a three-dimensional tissue system. ## Methods: Rabbit periosteal explants were cultured with or w

Dosing and scheduling influence the anti
✍ Vincent Dive; Kumari L. Andarawewa; Anne Boulay; Magdalini Matziari; Fabrice Bea πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 290 KB

## Abstract The __in vivo__ disposition and antitumor efficacy of a newly developed phosphinic matrix metalloproteinase inhibitor (RXP03) were examined. RXP03 potently inhibits MMP‐11, MMP‐8 and MMP‐13, but not MMP‐1 and MMP‐7. Twenty‐four hours after i.p. injection into mice, most of the RXP03 was

Prinomastat, a hydroxamate inhibitor of
✍ Elena I. Deryugina; Boris I. Ratnikov; Alex Y. Strongin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 301 KB

Membrane type-1 matrix metalloproteinase (MT1-MMP) and alphavbeta3 integrin have been directly implicated in tumor cell dissemination and metastasis. We have demonstrated that in the case of breast carcinoma MCF7 cells co-expressing MT1-MMP and alphavbeta3 integrin, the proteinase processes the pro-